Publications and Research
Document Type
Article
Publication Date
12-13-2017
Abstract
Transcription activator like effector nucleases (TALENs) is a new and powerful technique in genetic engineering that can delete deleterious genes or add beneficial genes to organisms. It is being widely studied to improve crops and livestock, and is also being investigated clinically. Comparing the details of how both TALENs and its competitor, CRISPR-Cas9, function, reveals the potential advantages of TALENs. The growing literature, besides covering the scientific and technical aspects of TALENs, also includes pertinent information on regulatory aspects and the public’s perception and acceptance of TALENs.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Scholarly Communication Commons
Comments
This is the accepted manuscript of an article originally published in Science & Technology Libraries, available at https://doi.org/10.1080/0194262X.2017.1394248